CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 109 filers reported holding CHINA BIOLOGIC PRODS INC in Q2 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $12,441,000 | -32.8% | 110,000 | -40.5% | 0.17% | -19.7% |
| Q1 2017 | $18,511,000 | -36.2% | 185,000 | -31.5% | 0.21% | -63.8% |
| Q4 2016 | $29,032,000 | -13.7% | 270,140 | 0.0% | 0.59% | -28.8% |
| Q3 2016 | $33,627,000 | +24.5% | 270,140 | +6.3% | 0.83% | +30.3% |
| Q2 2016 | $27,013,000 | -1.5% | 254,140 | +6.0% | 0.63% | +8.9% |
| Q1 2016 | $27,411,000 | -10.3% | 239,840 | +11.6% | 0.58% | +6.6% |
| Q4 2015 | $30,570,000 | +56.1% | 214,840 | -1.2% | 0.55% | +57.8% |
| Q3 2015 | $19,580,000 | -14.4% | 217,481 | +9.4% | 0.35% | -7.7% |
| Q2 2015 | $22,885,000 | +124.7% | 198,866 | +86.1% | 0.38% | +74.4% |
| Q1 2015 | $10,184,000 | +42.9% | 106,866 | 0.0% | 0.22% | +61.7% |
| Q4 2014 | $7,126,000 | +40.8% | 106,866 | +13.6% | 0.13% | +14.7% |
| Q3 2014 | $5,061,000 | +21.0% | 94,045 | 0.0% | 0.12% | -6.5% |
| Q2 2014 | $4,182,000 | – | 94,045 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ariose Capital Management Ltd | 88,655 | $10,149,000 | 9.57% |
| WARBURG PINCUS LLC | 4,087,200 | $467,903,000 | 8.91% |
| RUDMAN ERROL M | 64,001 | $7,327,000 | 4.96% |
| INDUS CAPITAL PARTNERS, LLC | 378,518 | $43,333,000 | 4.22% |
| OBERWEIS ASSET MANAGEMENT INC/ | 90,105 | $10,315,000 | 2.98% |
| Ativo Capital Management LLC | 85,623 | $9,802,000 | 2.66% |
| Sensato Investors LLC | 113,296 | $12,970,000 | 2.31% |
| Cormorant Asset Management, LP | 111,500 | $12,765,000 | 1.92% |
| BARING ASSET MANAGEMENT Ltd | 128,784 | $14,743,000 | 1.23% |
| Visium Asset Management, LP | 484,619 | $55,479,000 | 0.94% |